Skip to Main content Skip to Navigation
Journal articles

Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”

Abstract : No abstract available
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-03090462
Contributor : Christine Dupuis <>
Submitted on : Tuesday, December 29, 2020 - 4:48:58 PM
Last modification on : Wednesday, December 30, 2020 - 3:32:06 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Pierre Ambrosi, Aurélie Daumas, Patrick Villani, Roch Giorgi. Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”. Cardiology, Karger, 2020, 145 (6), pp.387-387. ⟨10.1159/000507361⟩. ⟨inserm-03090462⟩

Share

Metrics

Record views

115